These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 39047762)
1. Efficacy, Confounders and Safety of the Preserflo Microshunt. Altas C; Fuchsluger TA; Brockmann T; Graumüller A; Walckling M Klin Monbl Augenheilkd; 2024 Sep; 241(9):1048-1056. PubMed ID: 39047762 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of MicroShunt in Patients with Primary Open-Angle and Pseudoexfoliative Glaucoma: A Retrospective European Multicenter Study. Fea AM; Laffi GL; Martini E; Economou MA; Caselgrandi P; Sacchi M; Au L Ophthalmol Glaucoma; 2022; 5(2):210-218. PubMed ID: 34478904 [TBL] [Abstract][Full Text] [Related]
3. Long-term Outcomes of PreserFlo MicroShunt versus XEN45 Gel Stent in Open-Angle Glaucoma. Nobl M; Freissinger S; Rudolph K; Vounotrypidis E; Kassumeh S; Priglinger S; Mackert MJ Klin Monbl Augenheilkd; 2024 Jul; 241(7):805-812. PubMed ID: 37673088 [TBL] [Abstract][Full Text] [Related]
6. Intermediate Outcomes of a Novel Standalone Ab Externo SIBS Microshunt With Mitomycin C. Schlenker MB; Durr GM; Michaelov E; Ahmed IIK Am J Ophthalmol; 2020 Jul; 215():141-153. PubMed ID: 32173344 [TBL] [Abstract][Full Text] [Related]
7. Five-Year Outcomes Prospective Study of Two First-Generation Trabecular Micro-Bypass Stents (iStent®) in Open-Angle Glaucoma. Saheb H; Donnenfeld ED; Solomon KD; Voskanyan L; Chang DF; Samuelson TW; Ahmed IIK; Katz LJ Curr Eye Res; 2021 Feb; 46(2):224-231. PubMed ID: 32715828 [TBL] [Abstract][Full Text] [Related]
8. 1-year outcomes of the Xen45 glaucoma implant. Smith M; Charles R; Abdel-Hay A; Shah B; Byles D; Lim LA; Rossiter J; Kuo CH; Chapman P; Robertson S Eye (Lond); 2019 May; 33(5):761-766. PubMed ID: 30552422 [TBL] [Abstract][Full Text] [Related]
9. Matched case-control comparison of surgical success after XEN45 Gel Stent and PRESERFLO MicroShunt implantation in a Caucasian population. Lüke JN; Dietlein TS; Widder RA; Roessler GF; Lüke V; Enders P; Lappa A; Kiessling D Clin Exp Ophthalmol; 2024; 52(7):732-739. PubMed ID: 38841836 [TBL] [Abstract][Full Text] [Related]
10. PreserFlo™ MicroShunt Versus Trabeculectomy in Patients With Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study. Fili S; Kontopoulou K; Vastardis I; Perdikakis G; Kohlhaas M Cureus; 2022 Aug; 14(8):e28288. PubMed ID: 36158358 [TBL] [Abstract][Full Text] [Related]
11. Device-modified trabeculectomy for glaucoma. Park J; Rittiphairoj T; Wang X; E JY; Bicket AK Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010472. PubMed ID: 36912740 [TBL] [Abstract][Full Text] [Related]
12. Safety and Efficacy of the Preserflo Majoulet A; Scemla B; Hamard P; Brasnu E; Hage A; Baudouin C; Labbé A J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498660 [No Abstract] [Full Text] [Related]
13. Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma. Rauchegger T; Angermann R; Willeit P; Schmid E; Teuchner B Acta Ophthalmol; 2021 Jun; 99(4):369-375. PubMed ID: 32996702 [TBL] [Abstract][Full Text] [Related]
16. One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis. Tanner A; Haddad F; Fajardo-Sanchez J; Nguyen E; Thong KX; Ah-Moye S; Perl N; Abu-Bakra M; Kulkarni A; Trikha S; Lascaratos G; Parnell M; Kailani O; King AJ; Agrawal P; Stead R; Giannouladis K; Rodrigues I; Goyal S; Hysi PG; Lim S; Yu-Wai-Man C Br J Ophthalmol; 2023 Aug; 107(8):1104-1111. PubMed ID: 35365491 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients With Glaucoma. Strzalkowska A; Strzalkowski P; Hoffmann EM; Pfeiffer N; Schuster AK J Glaucoma; 2023 Aug; 32(8):681-685. PubMed ID: 37327469 [TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes and Cost Analysis of PreserFlo versus Trabeculectomy for Glaucoma Management in the United Kingdom. Van Lancker L; Saravanan A; Abu-Bakra M; Reid K; Quijano C; Goyal S; Rodrigues I; Lascaratos G; Trikha S; Barwood C; Combe E; Kulkarni A; Lim KS; Low S Ophthalmol Glaucoma; 2023; 6(4):342-357. PubMed ID: 36427750 [TBL] [Abstract][Full Text] [Related]
19. Intermediate-term impact on corneal endothelial cells and efficacy of Preserflo MicroShunt implantation in patients with open-angle glaucoma - a prospective study over two years. Gassel CJ; Wenzel DA; Nasyrov E; Strasser T; Voykov B Graefes Arch Clin Exp Ophthalmol; 2024 May; ():. PubMed ID: 38771337 [TBL] [Abstract][Full Text] [Related]
20. Trabeculectomy in the 21st century: a multicenter analysis. Kirwan JF; Lockwood AJ; Shah P; Macleod A; Broadway DC; King AJ; McNaught AI; Agrawal P; Ophthalmology; 2013 Dec; 120(12):2532-2539. PubMed ID: 24070811 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]